Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vanderbilt Minerals is a leading supplier of high-purity mineral excipients and specialty chemicals, primarily serving the pharmaceutical and personal care industries. The company is widely recognized for its VEEGUM® (magnesium aluminum silicate) and VAN GEL® (bentonite) product lines, which are used as stabilizers, rheology modifiers, and suspension agents in complex formulations. These mineral-based ingredients are critical for the production of topical creams, oral suspensions, and dental care products, meeting stringent USP-NF and EP pharmacopeia standards. As a subsidiary of R.T. Vanderbilt Holding Company, the firm leverages over a century of expertise in mineral processing and chemical distribution. Vanderbilt Minerals provides extensive technical and regulatory support to its global customer base, ensuring product consistency and performance. Their manufacturing facilities are focused on maintaining high-quality standards suitable for regulated healthcare applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vanderbilt Minerals.